Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Bright Horizons
BFAM
$3.76B
| $7.95M | 0.02% |
119,000
+18,500
| +18% | +$1.2M |
|
1152
World Kinect Corp
WKC
$1.89B
| $7.95M | 0.02% |
206,600
-27,388
| -12% | -$1.12M |
|
1153
Pegasystems
PEGA
$5.15B
| $7.94M | 0.02% |
577,448
+158,400
| +38% | +$2.19M |
|
|
NXTM
1154
DELISTED
NxStage Medical Inc.
NXTM
| $7.93M | 0.02% |
361,990
+66,500
| +23% | +$1.24M |
|
|
NATI
1155
DELISTED
National Instruments Corp
NATI
| $7.92M | 0.02% |
276,000
-16,300
| -6% | -$482K |
|
|
BDN
1156
Brandywine Realty Trust
BDN
$541M
| $7.91M | 0.02% |
578,898
-668,500
| -54% | -$8.83M |
|
|
ESGR
1157
DELISTED
Enstar Group
ESGR
| $7.89M | 0.02% |
52,600
+9,400
| +22% | +$1.45M |
|
1158
Cooper-Standard Automotive
CPS
$490M
| $7.89M | 0.02% |
101,654
+75,854
| +294% | +$5.36M |
|
|
CPGX
1159
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| $7.88M | 0.02% |
394,200
-1,546,903
| -80% | -$30.7M |
|
|
QEP
1160
DELISTED
QEP RESOURCES, INC.
QEP
| $7.88M | 0.02% |
587,800
-516,200
| -47% | -$7.52M |
|
|
THS
1161
DELISTED
Treehouse Foods
THS
| $7.86M | 0.02% |
+100,200
| New | +$8.36M |
|
1162
HDFC Bank
HDB
$119B
| $7.85M | 0.02% |
510,000
+425,200
| +501% | +$6.43M |
|
1163
American Public Education
APEI
$826M
| $7.82M | 0.02% |
420,200
+46,700
| +13% | +$1.03M |
|
1164
A10 Networks
ATEN
$2B
| $7.79M | 0.02% |
1,186,700
+665,000
| +127% | +$4.61M |
|
1165
Griffon
GFF
$4.75B
| $7.76M | 0.02% |
436,251
+261,351
| +149% | +$4.57M |
|
|
SVA
1166
DELISTED
Sinovac Biotech, Ltd
SVA
| $7.75M | 0.02% |
1,354,100
+61,321
| +5% | +$330K |
|
1167
Vertex Pharmaceuticals
VRTX
$133B
| $7.72M | 0.02% |
+61,317
| New | +$7.4M |
|
|
CCRN
1168
DELISTED
Cross Country Healthcare
CCRN
| $7.71M | 0.02% |
470,618
+138,400
| +42% | +$2.2M |
|
1169
Ternium
TX
$10.8B
| $7.7M | 0.02% |
619,300
+326,200
| +111% | +$4.55M |
|
|
EFOR
1170
Everforth Inc
EFOR
$1.34B
| $7.67M | 0.02% |
170,694
+107,700
| +171% | +$4.71M |
|
|
PHH
1171
DELISTED
PHH Corporation
PHH
| $7.66M | 0.02% |
472,600
+65,300
| +16% | +$1.01M |
|
|
ALX
1172
Alexander's
ALX
$1.39B
| $7.64M | 0.02% |
19,900
| – | – |
|
1173
Hexcel
HXL
$7.74B
| $7.63M | 0.02% |
164,200
+142,900
| +671% | +$6.6M |
|
|
EMBJ
1174
Embraer S.A. ADS
EMBJ
$13.2B
| $7.57M | 0.02% |
256,200
+228,200
| +815% | +$6.68M |
|
1175
BOK Financial
BOKF
$8.8B
| $7.57M | 0.02% |
126,542
+43,800
| +53% | +$2.87M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.